WSTAM
IART icon

Wilbanks Smith & Thomas Asset Management’s Integra LifeSciences IART Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12
Closed -$1K – 785
2018
Q3 		$1K Buy
+12
New +$746 ﹤0.01% 1522

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's IART Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 12 shares — an estimated $1K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in IART in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 12 Integra LifeSciences shares in Q4 2018, an estimated $1K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Integra LifeSciences in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Integra LifeSciences position peaked at $1K in Q3 2018.
  • 248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.